Free shipping on all orders over $ 500

BMS-986299

Cat. No. M20827

All AbMole products are for research use only, cannot be used for human consumption.

BMS-986299 Structure
Size Price Availability Quantity
1mg USD 55  USD55 In stock
5mg USD 110  USD110 In stock
10mg USD 180  USD180 In stock
25mg USD 360  USD360 In stock
50mg USD 535  USD535 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

BMS-986299 is a first-in-class (first-in-class) NLRP3 inflammatory vesicle agonist that induces IL8 release to activate natural killer (NK) cells with an EC50 of 1.28 μM.

Chemical Information
Molecular Weight 349.39
Formula C18H19N7O
CAS Number 2242952-69-6
Solubility (25°C) DMSO 70 mg/mL
Water 17 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Cong Bi, et al. J Org Chem. Coupling-Condensation Strategy for the Convergent Synthesis of an Imidazole-Fused 2-Aminoquinoline NLRP3 Agonist

Related NLR Products
SLC3037

SLC3037 is a NLRP3 inhibitor which blocks NLRP3 from binding to NEK7 or oligomerization, inhibiting inflammasome caused by MSU and other inflammasome activators.

FK 565

FK 565 is an immunoactive peptide and a nucleotide-binding oligomerization domain (Nod)-1 ligand agonist.

NBC19 

NBC19 is an NLRP3 inflammasome inhibitor with an IC50 of 60 nM in differentiated THP1 cells.

NT-0249 

NT-0249 is an orally active NLRP3 inhibitor.

BAL-0028 

BAL-0028 is a NLRP3 activation inhibitor with a IC50 value of 25 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: BMS-986299 supplier, NLR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.